Published in Eur J Neurosci on September 01, 2004
Glutamatergic substrates of drug addiction and alcoholism. Biochem Pharmacol (2007) 3.06
Cellular and behavioral interactions of gabapentin with alcohol dependence. J Neurosci (2008) 1.91
Molecular targets for antiepileptic drug development. Neurotherapeutics (2007) 1.78
Amphetamine toxicities: classical and emerging mechanisms. Ann N Y Acad Sci (2010) 1.62
Glutamatergic medications for the treatment of drug and behavioral addictions. Pharmacol Biochem Behav (2011) 1.38
New Horizons in the development of antiepileptic drugs: Innovative strategies. Epilepsy Res (2006) 1.32
Pregabalin abuse and dependence in Germany: results from a database query. Eur J Clin Pharmacol (2013) 1.09
Computational models of neuronal biophysics and the characterization of potential neuropharmacological targets. Curr Med Chem (2008) 1.06
Levetiracetam inhibits glutamate transmission through presynaptic P/Q-type calcium channels on the granule cells of the dentate gyrus. Br J Pharmacol (2009) 1.03
Diverse antiepileptic drugs increase the ratio of background synaptic inhibition to excitation and decrease neuronal excitability in neurones of the rat entorhinal cortex in vitro. Neuroscience (2010) 0.99
New molecular targets for antiepileptic drugs: alpha(2)delta, SV2A, and K(v)7/KCNQ/M potassium channels. Curr Neurol Neurosci Rep (2008) 0.99
Evidence that pregabalin reduces neuropathic pain by inhibiting the spinal release of glutamate. J Neurochem (2010) 0.97
Methodology for rapid measures of glutamate release in rat brain slices using ceramic-based microelectrode arrays: basic characterization and drug pharmacology. Brain Res (2011) 0.92
Felbamate but not phenytoin or gabapentin reduces glutamate release by blocking presynaptic NMDA receptors in the entorhinal cortex. Epilepsy Res (2007) 0.90
Amperometric measurement of glutamate release modulation by gabapentin and pregabalin in rat neocortical slices: role of voltage-sensitive Ca2+ α2δ-1 subunit. J Pharmacol Exp Ther (2011) 0.89
Gabapentin inhibits catecholamine release from adrenal chromaffin cells. Anesthesiology (2012) 0.87
Gabapentin decreases epileptiform discharges in a chronic model of neocortical trauma. Neurobiol Dis (2012) 0.87
P/Q-type calcium channel modulators. Br J Pharmacol (2012) 0.84
Pregabalin modulation of neurotransmitter release is mediated by change in intrinsic activation/inactivation properties of ca(v)2.1 calcium channels. J Pharmacol Exp Ther (2010) 0.83
Disturbance of consciousness and involuntary movements caused by pregabalin. BMJ Case Rep (2012) 0.83
Effects of gabapentin and pregabalin on K+-evoked 3H-GABA and 3H-glutamate release from human neocortical synaptosomes. Naunyn Schmiedebergs Arch Pharmacol (2008) 0.82
Pregabalin reduces alcohol drinking and relapse to alcohol seeking in the rat. Psychopharmacology (Berl) (2011) 0.81
Gabapentin alleviates facet-mediated pain in the rat through reduced neuronal hyperexcitability and astrocytic activation in the spinal cord. J Pain (2013) 0.80
Gabapentin potentiates sensitivity to the interoceptive effects of alcohol and increases alcohol self-administration in rats. Neuropharmacology (2015) 0.79
Pregabalin in acute and chronic pain. J Anaesthesiol Clin Pharmacol (2011) 0.78
In vivo imaging reveals that pregabalin inhibits cortical spreading depression and propagation to subcortical brain structures. Proc Natl Acad Sci U S A (2017) 0.78
Resolution of pregabalin and mirtazapine associated restless legs syndrome by bupropion in a patient with major depressive disorder. Psychiatry Investig (2009) 0.76
Clinical utility, safety, and efficacy of pregabalin in the treatment of fibromyalgia. Drug Healthc Patient Saf (2016) 0.75
A comparative study of pre-operative oral clonidine and pregabalin on post-operative analgesia after spinal anesthesia. Anesth Essays Res (2015) 0.75
Neuroprotective Effects of Pregabalin on Cerebral Ischemia and Reperfusion. Balkan Med J (2016) 0.75
Review about gabapentin misuse, interactions, contraindications and side effects. J Exp Pharmacol (2017) 0.75
The pilocarpine model of temporal lobe epilepsy. J Neurosci Methods (2008) 2.65
Inhibition of neuronal Ca(2+) influx by gabapentin and pregabalin in the human neocortex. Neuropharmacology (2002) 2.09
Tonic facilitation of glutamate release by presynaptic NR2B-containing NMDA receptors is increased in the entorhinal cortex of chronically epileptic rats. J Neurosci (2006) 1.40
Functional CB2 type cannabinoid receptors at CNS synapses. Neuropharmacology (2009) 1.17
Functional characterization of GABAergic pallidopallidal and striatopallidal synapses in the rat globus pallidus in vitro. Eur J Neurosci (2008) 0.98
Background synaptic activity in rat entorhinal cortical neurones: differential control of transmitter release by presynaptic receptors. J Physiol (2004) 0.95
GABA(A) alpha-1 subunit mediated desynchronization of elevated low frequency oscillations alleviates specific dysfunction in stroke--a case report. Clin Neurophysiol (2010) 0.92
Fundamental differences in spontaneous synaptic inhibition between deep and superficial layers of the rat entorhinal cortex. Hippocampus (2005) 0.91
Felbamate but not phenytoin or gabapentin reduces glutamate release by blocking presynaptic NMDA receptors in the entorhinal cortex. Epilepsy Res (2007) 0.90
Mobility of NMDA autoreceptors but not postsynaptic receptors at glutamate synapses in the rat entorhinal cortex. J Physiol (2008) 0.90
Amperometric measurement of glutamate release modulation by gabapentin and pregabalin in rat neocortical slices: role of voltage-sensitive Ca2+ α2δ-1 subunit. J Pharmacol Exp Ther (2011) 0.89
Depression of glutamate and GABA release by presynaptic GABAB receptors in the entorhinal cortex in normal and chronically epileptic rats. Neurosignals (2007) 0.87
Neurokinin-receptor-mediated depolarization of cortical neurons elicits an increase in glutamate release at excitatory synapses. Eur J Neurosci (2002) 0.85
Depolarisation and suppression of burst firing activity in the mouse subthalamic nucleus by dopamine D1/D5 receptor activation of a cyclic-nucleotide gated non-specific cation conductance. Neuropharmacology (2008) 0.85
Oscillatory beta activity mediates neuroplastic effects of motor cortex stimulation in humans. J Neurosci (2013) 0.85
Valproate modifies spontaneous excitation and inhibition at cortical synapses in vitro. Neuropharmacology (2003) 0.84
Lamina-specific differences in GABA(B) autoreceptor-mediated regulation of spontaneous GABA release in rat entorhinal cortex. Neuropharmacology (2004) 0.82
The role of NMDA receptor subtypes in short-term plasticity in the rat entorhinal cortex. Neural Plast (2008) 0.81
A multimodal perspective on the composition of cortical oscillations. Front Hum Neurosci (2013) 0.80
Modulation of network oscillatory activity and GABAergic synaptic transmission by CB1 cannabinoid receptors in the rat medial entorhinal cortex. Neural Plast (2008) 0.80
Comparison of the ORL1 receptor-mediated inhibition of noradrenaline release in human and rat neocortical slices. Br J Pharmacol (2002) 0.80
Ethosuximide modifies network excitability in the rat entorhinal cortex via an increase in GABA release. Neuropharmacology (2011) 0.79
Pre- and post-synaptic functions of kainate receptors at glutamate and GABA synapses in the rat entorhinal cortex. Hippocampus (2011) 0.77
Neuronal plasticity in the entorhinal cortex. Neural Plast (2008) 0.76
Carboxylate bioisosteres of gabapentin. Bioorg Med Chem Lett (2005) 0.75